Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1456]

FDA approves rucaparib for maintenance treatment of recurrent ovarian, fallopian tube, or primary peritoneal cancer

FDA approves rucaparib for maintenance treatment of recurrent ovarian, fallopian tube, or primary peritoneal cancer

Findings from breast and gynaecological cancer study may have potential for future clinical application

Findings from breast and gynaecological cancer study may have potential for future clinical application

Accurately diagnosing genetic disease prevents cancer, saves lives

Accurately diagnosing genetic disease prevents cancer, saves lives

New data suggests cervical cancer screening guidelines need to be reconsidered

New data suggests cervical cancer screening guidelines need to be reconsidered

Repurposing inhibitors may provide new treatment approach for ovarian cancer

Repurposing inhibitors may provide new treatment approach for ovarian cancer

The connection between diet, obesity, and cancer: Nutrition experts explore the evidence

The connection between diet, obesity, and cancer: Nutrition experts explore the evidence

Patients to skip the lab, get immediate results with new blood test technology

Patients to skip the lab, get immediate results with new blood test technology

Researchers examine role of fluid flow in ovarian cancer progression

Researchers examine role of fluid flow in ovarian cancer progression

Women with DCIS at lowest risk of recurrence if they are post-menopausal or have oestrogen receptor positive cancer

Women with DCIS at lowest risk of recurrence if they are post-menopausal or have oestrogen receptor positive cancer

AACR 2018: Chlamydia infection is associated with increased risk of ovarian cancer

AACR 2018: Chlamydia infection is associated with increased risk of ovarian cancer

More from ecancer